| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_424db9d56b06a23aed410fcf5df652f3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D7-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D101-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D7-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D101-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D7-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L1-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09D7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09D101-32 |
| filingDate |
2017-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37aa7080dfa2a28e7dbe5e24b0994ce0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07b9aab11cab06061329bb5eee41c339
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ebe5345cb4daaf6211c67421bab2630
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a3d70e553d5a70ea3f1108f6b265bd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c8fc3a4ab47186bf6913cabcead71a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daaaa55079928b292ee22f895d1ca619 |
| publicationDate |
2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9884922-B2 |
| titleOfInvention |
Hypromellose acetate succinate, method for producing the same and composition containing the same |
| abstract |
Provided are hypromellose acetate succinate (HPMCAS) which exhibits high solubility and can suppress generation of undissolved materials when dissolved in a solvent; an HPMCAS-containing composition; and a method for producing the HPMCAS. More specifically, provided are HPMCAS having a ratio of 2-position MS to 3-position MS of 1.2 or less, wherein the 2-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on 2-position carbon of each glucose unit of the HPMCAS has been directly replaced, and the 3-position MS means a molar substitution of hydroxypropyl group by which a hydrogen atom of a hydroxyl group on 3-position carbon of each glucose unit of the HPMCAS has been directly replaced; a composition comprising the HPMCAS and a solvent; and the method for producing the HPMCAS. |
| priorityDate |
2016-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |